Skip to main content

cPass® SARS-CoV-2 Neutralization Antibody Detection Kit

EUA

The GenScript cPass® SARS-CoV-2 kit is a blocking ELISA detection kit that can help to detect generated neutralizing antibodies in patient samples that prevent binding of the receptor binding domain (RBD) of the spike virus to the angiotensin converting enzyme-2 (ACE-2) of the host cell receptor, thus preventing COVID-19 infection propagation.

The cPass® SARS-CoV-2 Neutralization Antibody Detection Kit been authorized by FDA under an EUA for use by authorized laboratories of in vitro diagnostics for qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum and K2-EDTA plasma in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a that meet requirements to perform high complexity tests.
This test has been authorized by FDA under EUA for use by authorized laboratories.

Product Details Related Products Promotions
No data to display
This product is not available for purchase by the general public.
1-10 of 40 results
Items were successfully added to your cart!
Success

0 part selected.

Clear All